Market-Moving News for August 29th
Portfolio Pulse from Benzinga Newsdesk
BioCardia, Innovative Eyewear, and Affirm see significant stock price increases. BioCardia's rise follows FDA clearance for a new product, Innovative Eyewear benefits from a new sales channel, and Affirm reports strong earnings and guidance.
August 29, 2024 | 12:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Affirm shares increased 23% following strong Q4 earnings and positive Q1 guidance.
Affirm's strong Q4 earnings and optimistic Q1 guidance likely boosted investor confidence, resulting in a significant stock price increase.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
BioCardia shares surged 162% after receiving FDA clearance to market its Morph DNA Steerable Introducer product family.
FDA clearance is a significant milestone for BioCardia, allowing them to market a new product, which likely drove the stock price up significantly.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Innovative Eyewear shares rose 72% after announcing that its Lucyd Lyte frames are now available on Target.com.
The availability of Lucyd Lyte frames on Target.com expands Innovative Eyewear's sales channels, likely boosting investor confidence and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100